2nd Quarter - Report
AKIN GUMP STRAUSS HAUER & FELD for AMGEN USA, INC.
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Home health options for Part B drugs; legislative response to COVID-19; monitor drug pricing legislation including Prescription Drug Pricing Act (S. 2543), the Lower Costs, More Cures Act (S. 3129).
| Lobbyist | Covered position, as disclosed |
|---|---|
| GORDON HUNTER BATES | — |
| VIRGIL MILLER New | Policy Fellow, Rep. Edolphus Towns, Aug06 - Feb07; Prof Staff Mber, Commit on Eng and Com, Feb 07 - Jan 11; Health Policy Advisor, Rep. John D. Dingell, Jan 09 - Jan 11; CoS, Rep. Cedric Richmond, Jan 11 - Mar 19. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.